NCT03337581

Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric

The Safety、Efficacy and Pharmacokinetics of Dexmedetomidine Administered Through Different Routes in Pediatric

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 187 (estimated)
• Sponsor: Chinese Medical Association · Network
• Sex: All
• Age: 3 Years – 9 Years
• Healthy volunteers: Not accepted

Summary

1. Acute Hemodynamic and respiratory Changes After Rapid Intravenous different doses of Dexmedetomidine in Pediatric. 2. Pharmacokinetics after a single Rapid Intravenous dose of Dexmedetomidine in Pediatric. 3. Pharmacokinetics after a single dose of Dexmedetomidine administered as a nasal spray in Pediatric.

Conditions

• Pediatrics
• Dexmedetomidine
• Pharmacodynamics
• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	see arms

Timeline

• Start date: 2017-10-20
• Primary completion: 2018-12-01
• Completion: 2019-07-01
• First posted: 2017-11-09
• Last updated: 2017-11-09

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study